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High Complexity in the Expression of the B* Subunit of Protein
Phosphatase 2A0
EVIDENCE FOR THE EXISTENCE OF AT LEAST SEVEN NOVEL ISOFORMS*
(Received for publication, September 29, 1995, and in revised form, November 28, 1995)
Csilla Csortos‡, Stanislaw Zolnierowicz§, Eva Bako´, Stephen D. Durbin,
and Anna A. DePaoli-Roach¶
From the Department of Biochemistry and Molecular Biology, Indiana University School of Medicine,
Indianapolis, Indiana 46202-5122
Association of the catalytic subunit (C2) with a variety
of regulatory subunits is believed to modulate the activ-
ity and specificity of protein phosphatase 2A (PP2A). In
this study we report the cloning and expression of a new
family of B-subunit, the B*, associated with the PP2A0
form. Polymerase chain reactions and cDNA library
screening have identified at least seven cDNA isotypes,
designated a, b1, b2, b3, b4, g, and d. The different b
subtypes appear to be generated by alternative splicing.
The deduced amino acid sequences of the a, b2, b3, b4
and g isoforms predict molecular weights of 57,600,
56,500, 60,900, 52,500, and 68,000, respectively. The pro-
teins are 60–80% identical and differ mostly at their
termini. Two of the isoforms, B*b3 and B*g, contain a
bipartite nuclear localization signal in their COOH ter-
minus. No homology was found with other B- or B-
related subunits. Northern analyses indicate a tissue-
specific expression of the isoforms. Expression of
B*a protein in Escherichia coli generated a polypeptide
of ;53 kDa, similar to the size of the B* subunit present
in the purified PP2A0. The recombinant protein was
recognized by antibody raised against native B* and
interacted with the dimeric PP2A (A•C2) to generate a
trimeric phosphatase. The deduced amino acid se-
quences of the B* isoforms show significant homology to
mammalian, fungal, and plant nucleotide sequences of
unknown function present in the data bases. Notably, a
high degree of homology (55–66%) was found with a
yeast gene, RTS1, encoding a multicopy suppressor of a
rox3 mutant. Our data indicate that at least seven B*
subunit isoforms may participate in the generation of a
large number of PP2A0 holoenzymes that may be spa-
tially and/or functionally targeted to different cellular
processes.
Protein phosphatase 2A (PP2A)1 is one of the major serine/
threonine protein phosphatases present in the cell and is in-
volved in the control of many cellular functions and metabolic
pathways (reviewed by Cohen (1989), Mumby and Walter
(1993), DePaoli-Roach et al. (1994), and Mayer-Jaekel and
Hemmings (1994)). The Ser/Thr protein phosphatases, with the
exception of PP2C, consist of multimeric structures. Their cat-
alytic subunit associates with specific proteins, which serve as
targeting/regulatory subunits and play substantial roles in the
control of phosphatase activity.
PP2A is a family of holoenzymes containing a common core of
a 36-kDa catalytic (C2) subunit and a 63-kDa A subunit asso-
ciated with a variety of regulatory B-subunits (B, B9, and B0) to
form the trimeric PP2A1, PP2A0, and polycation-stimulated
protein phosphatase M, respectively (Tung et al., 1985; Waelk-
ens et al., 1987; Mumby et al., 1987; Zolnierowicz et al., 1994).
Takeda and co-workers (Usui et al., 1988) also isolated from
human erythrocytes a PP2A form that contained a polypeptide
of 74 kDa associated with the AzC2 core. Molecular cloning has
identified in mammals two isoforms each of the C2 (da Cruz e
Silva and Cohen, 1987; Green et al., 1987; Stone et al., 1987)
and the A (Walter et al., 1989, 1990; Hemmings et al., 1990)
subunits, which are evolutionarily highly conserved.
The B-subunit is the most diverse and comes in three vari-
ants, B, B9, and B0, of ;52, 53, and 74–130 kDa, respectively.
The B subunit, associated with PP2A1, and the B9 subunit,
associated with PP2A0, appear to be structurally unrelated
based on peptide mapping (Tung et al., 1985) and immunore-
activity (Zolnierowicz et al., 1994). Molecular cloning of the B
subunit has identified three closely related isoforms, a, b and g
(Healy et al., 1991; Mayer et al., 1991; Zolnierowicz et al., 1994),
that are more than 80% identical. Drosophila (Mayer-Jaekel et
al., 1993; Uemura et al., 1993) and Saccharomyces cerevisiae
(Healy et al., 1991) homologs have also been isolated. Cloning of
the cDNA for the B0 subunit, constituent of the polycation-
stimulated protein phosphatase M, predicts the existence of
two, 72- and 130-kDa, alternatively spliced forms (Hendrix et
al., 1993) that show no homology to the B subunit isoforms. The
dimeric AzC2 phosphatase has also been found to be associated
with polyomavirus middle and small tumor antigens and with
SV40 small tumor antigen (Pallas et al., 1990; Walter et al.,
1990).
The control of PP2A activity is not fully understood. Recent
reports suggest that post-translational modifications of the C2
subunit, such as phosphorylation and carboxymethylation,
might have regulatory function (Chen et al., 1992; Lee and
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Stock, 1993; Xie and Clarke, 1993; Turowski et al., 1995).
Several findings also point to a key role of the A and B-subunits
in the regulation of phosphatase activity. In vitro studies indi-
cate that the substrate specificity is affected by the subunit
composition (Imaoka et al., 1983; Cohen, 1989; Agostinis et al.,
1992; Kamibayashi et al., 1992, 1994). Association of the reg-
ulatory subunits with C2 has been demonstrated to cause ei-
ther increased or decreased activity toward different substrates
(Agostinis et al., 1992; Ferrigno et al., 1993; Mayer-Jaekel et
al., 1994).
Support for the involvement of the regulatory B-subunits in
the control of specific cellular functions comes from several
studies. Association of the SV40 and polyomavirus antigens
with the dimeric PP2A by displacement of the B-subunits
might subvert the function of the enzyme and contribute to cell
transformation (for a review see Mumby and Walter (1993)).
Transient expression of SV40 small t antigen in CV-1 cells
stimulated the mitogen-activated protein kinase pathway and
cell growth, most likely through inhibition of PP2A (Sontag et
al., 1993). Mutations of the B subunit were found to result in
defective cytokinesis in S. cerevisiae (Healy et al., 1991) and in
abnormal anaphase progression in Drosophila (Mayer-Jaekel
et al., 1993). Although the mechanisms responsible for the
defects are not completely understood, it appears that the B
subunit targets the phosphatase to distinct cellular structures
(Sontag et al., 1995) and/or confers substrate specificity
(Mayer-Jaekel et al., 1994).
Thus, strong evidence from different experimental ap-
proaches and systems points to a key role of the B-subunits in
the control of PP2A holoenzymes. The elucidation of their pri-
mary structure is a critical step toward understanding their
function. In this paper we report the isolation and character-
ization of cDNA clones encoding at least seven isoforms of the
B9 subunit of PP2A0 that are not related to other B-subunits.
The large number of isoforms identified and the relative tissue-
specific distribution of their mRNAs suggest that distinct ho-
loenzyme forms may be generated that either spatially and/or
functionally direct the enzyme to different cellular targets. The
high homology of the B9 subunit to sequences derived from
various organisms also indicate that the PP2A0 enzyme is
highly conserved through evolution.
EXPERIMENTAL PROCEDURES
Other Materials and Methods—Rabbit brain oligo(dT)-primed
lgt10 cDNA library was from Clontech Laboratories, Inc. Gene-
Scribe-Z vector, pTZ19, and random primed DNA labeling and se-
quencing kits were from the U. S. Biochemical Corp. M13 mp18 and
M13 mp19 vectors and Moloney murine leukemia virus reverse tran-
scriptase were from Life Technologies, Inc. Taq polymerase was ob-
tained from Perkin-Elmer. The TA cloning kit was from Invitrogen.
Restriction and other DNA modifying enzymes were from Life Tech-
nologies, Inc. or New England Biolabs. The pET-8c expression vector
was provided by Dr. F. W. Studier (Brookhaven National Laboratory),
and the pET-15b vector was from Novagen. Oligonucleotides were
synthesized on an Applied Biosystems DNA synthesizer model 380A.
Rabbit skeletal muscle dimeric PP2A was generated after dissocia-
tion of the B subunit from PP2A1 (Zolnierowicz et al., 1994). Antibod-
ies against the B9 subunit of bovine heart PP2A (Mumby et al., 1987)
and the catalytic subunit of PP2A (Mumby et al., 1985) were kindly
provided by Dr. Marc Mumby, University of Texas Health Science
Center, Dallas. Radionucleotides and 125I-protein A were purchased
from DuPont NEN and ICN, respectively. The molecular weight-SDS
calibration kit was from Pharmacia Biotech Inc. Protein concentra-
tion was determined by the method of Bradford (1976) using bovine
serum albumin as standard.
Isolation and Sequencing of B9 Subunit Peptides—The AzB9zC2 trim-
eric PP2A0 was purified to apparent homogeneity from rabbit skeletal
muscle as described in Zolnierowicz et al. (1994). The subunits (80 mg)
were separated by SDS-PAGE (Laemmli, 1970) and electroblotted onto
a nitrocellulose membrane. After staining with 0.1% Ponceau S in 5%
acetic acid, the regions corresponding to the A (;34 mg), B9 (;28 mg),
and C2 (;23 mg) subunits were excised, and each subunit was digested
in situ with trypsin at a 10:1 (w/w) ratio overnight at 37 °C in 0.2 ml of
100 mM Tris-HCl (pH 8.2) containing 5% acetonitrile (Aebersold et al.,
1987). The resulting soluble tryptic peptides were resolved by C-18
reverse-phase chromatography on a microbore Applied Biosystems
130A Separating System. Peak fractions were collected manually, and
the peptides were subjected to automated Edman degradation on a
Porton Instrument model 2090 Integrated Micro-Sequencing System
(Tarzana, California).
Amplification of Rabbit Skeletal Muscle mRNA—Degenerate oligo-
nucleotides were synthesized based on the amino acid sequence of four
B9 subunit peptides; oligonucleotides 1 (59-TT(T/C)CTIGA(A/G)TCI-
CA(A/G)GA(A/G)TT(T/C)CA(A/G)CC-39), 2 (59-AA(T/C)GA(A/G)TT(T/
C)TGGGGNGA(A/G)GA(A/G)CTIGA-39), 3 (59-GA(A/G)GTNATGTT(T/
C)CTNGG-39), and 4 (59-CA(A/G)ACNTA(T/C)CCNGA(A/G)GT-39)
encoded the amino acid sequences FLESQEFQP, NEFWGEELE, EVM-
FLG, and QTYPEV, respectively. The complementary strands of oligo-
nucleotides 1 and 2 were also made.
Reverse transcriptase polymerase chain reactions (PCR) were per-
formed using degenerate oligonucleotide primers and rabbit skeletal
muscle mRNA. Total RNA from rabbit skeletal muscle was purified
according to Chomczynski and Sacchi (1987). Poly(A)1 RNA was iso-
lated by affinity chromatography on oligo(dT)-cellulose (5 Prime 3 3
Prime, Inc.). First strand cDNA was synthesized from 0.2 mg of mRNA
with Moloney murine leukemia virus reverse transcriptase (200 units)
and reverse oligonucleotide primers 1 or 2 (100 pmol) as described
previously (Healy et al., 1991). The single stranded cDNA was then
amplified with 100 pmol each of oligonucleotide 1, 2, 3, or 4 as forward
primer. The amplified products were separated on 1% agarose gel and
analyzed by Southern hybridization (Southern, 1975) with 59 end-
labeled oligonucleotides that had not been used in the amplification
reaction. A 641-bp DNA fragment, M PCR (Fig. 1), obtained with
oligonucleotides sense 1 and antisense 2, hybridized with the 59 end-
labeled oligonucleotide 3. The M PCR fragment was subcloned into
pCRTMII vector (TA Cloning System, Invitrogen) and sequenced by the
dideoxynucleotide chain termination method (Sanger et al., 1977) with
vector- and cDNA-specific oligonucleotide primers.
Isolation and Sequence Analysis of cDNA Library Clones—The
641-bp PCR fragment 32P-labeled by the random hexamer priming
method (Feinberg and Vogelstein, 1983) was used for initial screening
of 160,000 independent recombinants from an unamplified random
primed rabbit skeletal muscle lgt11 cDNA library (Zhang et al., 1989).
Positive clones were plaque purified by consecutive screenings, and the
cDNA inserts were subcloned into pTZ19U, M13 mp18, and M13 mp19
vectors for sequencing.
The initial screening of the rabbit skeletal muscle cDNA library with
the 641-bp M PCR fragment identified 38 positive clones. Fifteen clones
were rescreened, and nine held positive after plaque purification. Four
were fully characterized (M 2-1, 1338 bp; M 5-1, 1125 bp; M 1-1, 877 bp;
and M 6-2, 1157 bp; Fig. 1), and five were found to overlap with the
other four. Nucleotide sequence analysis of the cDNA clones showed
;70% identity to the M PCR sequence. The four clones fell into two
groups, one comprising M 2-1 and M 5-1 and the other comprising, M
1-1 and M 6-2 clones, indicating the existence of at least three isoforms.
The isoforms encoded by M 2-1/M 5-1, termed a, and by M 1-1/M 6-2,
termed b, shared 78 and 92% identity, respectively, with that encoded
by M PCR, termed g. The combined a cDNAs contained an open reading
frame with a stop codon close to the 39 end but did not have a transla-
tion start ATG codon. The b cDNAs had an ATG start codon but no stop
codon.
In order to obtain the complete coding sequences, the 59 end 367-bp
EcoRI–BglII and the 39 end 329-bp NaeI–EcoRI fragments of the a
isotype M 2-1 cDNA were used to rescreen the original filters. Out of
fifteen positive signals, eight were new clones. Seven were plaque
purified, and four of these (M 1-7B9a, 1013 bp; M 1-8B9a, 421 bp; M
5-4B9a, 537 bp; and M 7-1B9a, 819 bp) were sequenced (Fig. 1).
Because only partial clones were isolated for the B9b isoform, the
original filters of the rabbit skeletal muscle library were rescreened
with the labeled 59 end 343-bp EcoRI–PstI and the 39 end 395-bp
XbaI–EcoRI fragments of M 6-2B9b cDNA. Fifteen positive clones were
identified, only one of which, M 8-6B9b1 (1514 bp), extended the 59 and
39 ends (Fig. 1). This cDNA had an open reading frame with an ATG at
position 24, immediately preceded by a stop codon, but no stop codon
was present at the 39 end. Therefore the 59 428-bp EcoRI–PstI, the 39
304-bp XmnI–EcoRI, and the 39 426-bp RcaI–EcoRI fragments of M
8-6B9b1 were used for screening additional 320,000 recombinants of the
rabbit skeletal muscle cDNA library. Sequence analysis revealed that
the 39 end regions of five out of the eight clones characterized (M
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19-1B9b2, 316 bp; M 10-1B9b3, 620 bp; M 17-2B9b3, 922 bp; M 13-1B9b4,
515 bp; and M5-1B9b4, 1502 bp) diverged from the M 8-6B9b1 at
different positions (Fig. 1 and 3). The subtypes of the b isoform of the B9
subunit were termed b1, b2, b3, and b4.
320,000 additional recombinant l phages were also screened with the
radiolabeled 641-bp M PCR fragment in order to isolate g isotype
cDNAs. Two partial overlapping clones were identified, M 20-1B9g (996
bp) and M 23-1B9g (956 bp) (Fig. 1). Although there are 11 differences
(3 G/A and 8 T/C) between the nucleotide sequences of the 918 bp
overlapping portion of the two clones, their deduced amino acid se-
quences are identical, suggesting that they represent allelic forms. The
M 23-1B9g clone is identical to the M PCR in the overlapping region,
except for some differences in the primer regions. These cDNA clones
did not contain the complete coding sequence, and rescreening of the
rabbit skeletal library failed to provide additional sequences. Because
Northern analysis (see below) had indicated that the a and g isoforms
were most abundant in brain, 220,000 recombinants from a lgt10
rabbit brain oligo(dT)-primed cDNA library (Clontech Laboratories
Inc.) were screened with the 641-bp M PCR fragment, the 536-bp M
5-4B9a, the 421-bp M 1-8B9a, the 773-bp SspI–EcoRI fragment of M
2-1B9a, the 505-bp EcoRI–XbaI fragment, and the 665-bp XbaI–EcoRI
fragment of M 8-6B9b1. Several positive clones were isolated, eight of
which encoded B9g and two of which coded for a distinct isoform, termed
d (Fig. 1).
Amplification of DNA Fragments Spanning the B9g and B9X Clones—
First strand cDNA was synthesized from 5 mg of rabbit skeletal muscle
and brain total RNA using the reverse primer 59-CCCTGTCTGCGCAT-
GCC-39 (nucleotides 636–652 of clone BR 6-1 B9X; Fig. 1). For ampli-
fication, 1 ml of a 1:50 diluted reverse transcriptase reaction was used
with 50 pmol of the forward primer 59-GATTGCCGAGCTCCTGG-39,
derived from nucleotides 1128–1145 of BR 6-2 B9g clone (Fig. 1) and 50
pmol of the reverse primer 59-GCTTCCTTCTCTAGCTAGA-39 (nucleo-
tides 552–570 of BR 6-1 B9X clone). Products were analyzed on agarose
gel and by Southern hybridization. This procedure yielded 1045-bp
DNA fragments, both frommuscle and brain RNA, that hybridized with
both B9g- and B9X-specific probes. The fragments were subcloned into
the pCRTMII and M13 mp19 vectors and sequenced using vector- and
cDNA-specific primers.
Northern Analysis—Total RNA from different cell lines, rabbit and
rat tissues was isolated (Chomczynski and Sacchi, 1987). RNA samples
(20 mg) were fractionated on 0.8% agarose/formaldehyde gels and trans-
ferred to nitrocellulose membranes that were hybridized with 32P-
labeled isotype-specific cDNAs. The filters were subjected to autora-
diography using X-OMAT AR (Kodak) film with Du Pont Quanta III
intensifying screens.
Expression in Escherichia coli and Purification of the B9a Isoform—
The 410-bp NcoI–XmnI fragment of the cDNA clone M 1-7 (Fig. 1) was
ligated with the 1331-bp XmnI–EcoRI fragment of clone M 2-1 at the
XmnI site. This 1741-bp B9a cDNA was cloned into the pET-8c and into
the pET-15b vectors. The latter vector yields a B9a polypeptide with an
NH2-terminal hexahistidine sequence (His-tag). The generation of the
correct constructs was verified by restriction mapping and sequencing
using cDNA-specific oligonucleotide primers.
Plasmids B9azpET-8c and B9azpET-15b were transformed into E. coli
strain BL21(DE3). The cells were grown at 37 °C to an A600 of 0.8 units
and then induced for 2 h with 0.4 mM (B9azpET-8c) or 1.0 mM (B9azpET-
15b) isopropyl-1-thio-b-D-galactopyranoside. The cells were harvested
by centrifugation at 5,000 3 g for 15 min and lysed by 2 3 20 s
sonication in 10 volumes of 50 mM Tris-HCl (pH 7.5), 0.2% b-mercap-
toethanol, 1 mM phenylmethylsulfonyl fluoride, 1 mM benzamidine, 0.1
mM Na-p-tosyl-L-lysine-chloromethyl ketone, and 10 mg of leupeptin/ml.
After centrifugation at 10,000 3 g for 20 min, the soluble fraction was
removed. The pellet fraction was washed twice with the same buffer
containing 1% Triton X-100 and then resuspended in the same volume
of buffer without Triton X-100. The samples were analyzed by SDS-
PAGE andWestern immunoblotting using antibodies raised against the
bovine B9 subunit.
The insoluble cell fraction, containing the His-tagged B9a, prepared
from 100 ml of cultured E. coli, was solubilized in 50 mM Tris-HCl (pH
7.5) and 6 M guanidine-HCl at room temperature for 1 h. Renaturation
was carried out by a rapid 100-fold dilution of the solubilized proteins in
50 mM Tris-HCl (pH 7.5), 0.8 M NaCl, 0.4% b-mercaptoethanol, and
0.02% Tween 20 (Berndt and Cohen, 1990). After 2 h at room temper-
ature, ;1.2 ml of Ni21-NTA-agarose (QIAGEN)/liter of solution was
added and batch-absorption was allowed for 2 h at 4 °C. The resin was
then packed into a column and washed with 25 mM Tris-HCl (pH 7.5),
5 mM imidazole, and 0.8 M NaCl, followed by 25 mM Tris-HCl (pH 7.5),
20 mM imidazole, and 0.2 or 0.8 M NaCl. B9a was eluted with 100 or 200
mM imidazole in 25 mM Tris-HCl (pH 7.5) and 0.2 or 0.8 M NaCl.
Fractions were collected and analyzed by SDS-PAGE and Western
immunoblotting with B9 antibody.
Reconstitution of AzB9azC2 Complex—Approximately 8 mg (80 pmol)
of rabbit skeletal muscle dimeric PP2A (AzC2) was incubated in the
presence or the absence of ;1 mg (15 pmol) of purified His-tagged B9a at
4 °C for 1 h in 40 mM Tris-HCl (pH 7.5), 0.033 mM EGTA, 0.2 M NaCl,
16.7 mM imidazole, and 1 mM phenylmethylsulfonyl fluoride. Approxi-
mately 50 mg of Ni21-NTA-agarose were added to the sample and
stirred slowly for 1 h at 4 °C. The resin was then packed into a pipette
tip column and washed with 25 mM Tris-HCl (pH 7.5), 20 mM imidazole,
and 0.2 M NaCl. The bound proteins were eluted with 25 mM Tris-HCl
(pH 7.5), 100 mM imidazole, and 0.2 M NaCl. Aliquots were analyzed by
SDS-PAGE and Western immunoblotting. Control experiments were
performed in which the dimeric phosphatase, in the absence of B9a, was
applied to the Ni21-NTA-agarose, and the column was developed as
above.
Western Blot Analysis—Protein samples were separated on 9% SDS-
PAGE and electroblotted onto nitrocellulose as described in Tang et al.
(1991). Filters were incubated for 2 h with antibodies to the bovine
heart PP2A0 B9 subunit (Mumby et al., 1987), the 314–324 peptide of
Aa (Zolnierowicz et al., 1994), and the C2 (Mumby et al., 1985). Bound
antibodies were detected with 125I-protein A (0.2 mCi/ml) and
autoradiography.
RESULTS
Isolation and Sequence Analysis of Protein Phosphatase 2A0
B9 Subunit Peptides—The PP2A0 was purified from rabbit skel-
etal muscle as previously reported (Zolnierowicz et al., 1994).
The three subunits, A (61.5 kDa), B9 (52.5 kDa), and C2 (36
kDa), were separated by SDS-PAGE and initially electroblotted
onto a polyvinylidene difluoride membrane. NH2-terminal se-
quencing of the intact B9 polypeptide was not successful, indi-
cating that the NH2 terminus of the protein was probably
blocked. In situ tryptic digestion, purification, and microse-
quencing of the released peptides provided sequences for nine
B9 subunit tryptic peptides, EVMFLGELE, FLGLR,
FLESQEFQPS, TLPPSDSNEFWGEELE, IQEP, XXLTEQ-
TYPEV, XFMEMN, MXXXNIFR, and XPPXKPQGPPSQ, cov-
ering a total of 81 residues. Comparison of these amino acid
sequences with the predicted protein sequence of the B subunit
isoforms of PP2A1 (Mayer et al., 1991; Healy et al., 1991;
Zolnierowicz et al., 1994) and the B0 subunit of polycation-
stimulated protein phosphatase M (Hendrix et al., 1993) did
not reveal any significant homology.
Isolation and Characterization of a B9 Subunit PCR Frag-
ment—Of the various combinations of oligonucleotides used for
reverse transcriptase PCR of rabbit skeletal muscle mRNA, one
yielded a 641-bp product (Fig. 1, M PCR), which hybridized
with an oligonucleotide probe derived from the sequence of a
third peptide. In addition, the sequence of two other tryptic
peptides were found in the deduced amino acid sequence of the
PCR fragment: FLGLR was identical, and EVMFLGELE
showed only one amino acid difference, Asn for Gly.
Characterization of B9 a cDNA Clones—Initial screening of a
rabbit skeletal muscle cDNA library with the 641-bp PCR
fragment provided cDNA clones that fell into two groups, both
different from the M PCR, indicating the existence of three
isoforms, termed a, b, and g. Overlapping clones of the a
isoform provided a 2446-bp combined sequence that comprised
an open reading frame of 1500 nucleotides encoding a protein of
500 amino acids with a predicted molecular mass of 57.6 kDa
(Fig. 2). The M 1-7B9a clone contained an ATG codon at posi-
tion 498 preceded, 30 bp upstream, by an in frame stop codon.
The nucleotide sequence around this ATG (GCCCGCCCGC-
CATGG) conforms well to the consensus sequence for transla-
tion initiation in higher eukaryotes (Kozak, 1989). No poly-
adenylation signal or poly(A) tail was found in the 449 bp of
39-untranslated sequences. Comparison of the nucleotide se-
quences of the M 1-7B9a andM 7-1B9a cDNAs revealed that the
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two clones had overlapping, identical regions, but the 225–696
nucleotide region of M 1-7B9a cDNA was not present in the M
7-1B9a (Fig. 1). This deletion eliminated the initiator codon.
The significance of the deletion is not clear at this time. It is
possible that it represents an alternatively spliced variant of
B9a.
Analysis of B9b cDNA Clones—Rescreening of the muscle
library with b specific cDNA probes led to isolation of clones
that diverged at different positions in their 39 end regions (Figs.
1 and 3), most likely generated by alternative splicing. The
subtypes of the b isoform of the B9 subunit were termed b1, b2,
b3, and b4. Their deduced amino acid sequences are identical
up to residue 442 but diverge in their COOH termini (Fig. 3) at
positions in the nucleotide sequence corresponding to potential
splice sites (Fig. 3; Senapathy et al., 1990). The b4 subtype
starts to diverge at nucleotide 1350 of the M 8-6B9b1 and
contains a stop codon 21 nucleotides downstream from the
point of divergence. Combination of the common region and b4
cDNAs provides a 1509-nucleotide sequence containing an
open reading frame of 1347 bp, encoding a 52.5-kDa protein
that shares 64% identity and 74% homology (Table I) with the
a isoform. The 139-bp 39-untranslated region contains a poly-
adenylation signal 21 bp upstream of the 39 end, which may
contain the beginning of the poly(A) tail. This was confirmed by
amplification of the 39 end by reverse transcriptase PCR, which
generated a 260-bp fragment identical to the 39 region of the b4
cDNAs except for the presence of a stretch of 17 adenines at the
end.
The b2 and b3 clones start to diverge from b1 and from each
other at nucleotide 1467 (Fig. 3). The b2 cDNA has a stop codon
16 bp downstream, and the b3 cDNA has a stop codon 130 bp
downstream. Combination of the common region of the Bb
cDNAs with the b2 or b3 isotypes yields sequences of 1458 or
1572 nucleotides, encoding proteins with predicted molecular
weights of 56,500 or 60,900, respectively. Interestingly, the
divergent region of b3 contains a putative bipartite nuclear
localization signal RKTVSDEARQAQKDPKK (Dingwall and
Laskey, 1991; Robbins et al., 1991).
Characterization of B9g and d cDNAs—Screening of the mus-
cle library did not provide complete coding sequences for the g
isoform of B9 (Fig. 1 and 5). However, screening of a rabbit
brain library resulted in isolation of several cDNA clones. The
nucleotide sequences of the 39 end region of these cDNAs were
identical to those of the rabbit skeletal muscle M 23-1B9g and
the amplified M PCR fragment (Fig. 1). Restriction mapping
and partial sequence analysis revealed that the 59 region of the
rabbit brain g clones were different and showed no homology to
the corresponding regions of the other isoforms. Previous
screening of the same library had suggested that this brain
library might contain concatamers of unrelated cDNA frag-
ments (Zolnierowicz et al., 1994). Nevertheless, the BR 6-2B9g
brain cDNA (Fig. 1) contained an open reading frame of 1308
bp. An ATG codon, at nucleotide 289, is preceded 30 bp up-
stream by an in frame stop codon. Another rabbit brain clone,
BR 6-1B9X, had a 445-bp open reading frame ending with a stop
codon. Joining the BR 6-2B9g and BR 6-1B9X cDNAs at the
EcoRI site did not change the reading frame. Reverse tran-
scriptase PCR amplification from rabbit skeletal muscle and
brain RNA using as primers oligonucleotides derived from the
BR 6-2B9g and the BR 6-1B9X cDNAs yielded a 1045-bp product
(Fig. 1, B9g-X). This DNA fragment contained an internal
EcoRI site, confirming that the two cDNA clones pertained to
the same mRNA. Combined sequences of B9g and X cDNAs
provided a 1758-bp open reading frame encoding 586 amino
acids with a predicted molecular mass of 68 kDa (Fig. 4). The
muscle and brain B9g isoforms are identical (Fig. 5) and display
higher homology to the B9b isoforms (77–82%) than to the B9a
(61%) (Table I). In the NH2-terminal region, starting at amino
acid 21, there is an 8-fold glutamine-proline repetition, and in
the COOH-terminal 532–548 residues there is a putative bi-
FIG. 1. cDNA clones encoding protein phosphatase 2A0 B* sub-
unit. Clones were isolated from rabbit skeletal muscle (M) and rabbit
brain (BR) cDNA libraries. Thick solid lines indicate regions that were
sequenced in both direction. Thin lines indicate regions sequenced in
one direction. Dashed lines indicate regions not sequenced. The angled
line in clone M 7-1B9a indicate a deletion. Diverging sequences of the
different b forms are marked with different dashed lines. The sizes of
the individual clones are indicated in parentheses. Partial restriction
maps of cDNAs for different isoforms are also shown.
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partite nuclear localization signal.
Screening of the rabbit brain library identified two addi-
tional clones, BR 6-1B9d and BR 8-1B9d, that are identical at
the 39 end but differ at the 59 end (Fig. 1). This region might be
the result of the presence of concatamerization of brain cDNAs
in the library (Zolnierowicz et al., 1994). A putative translation
start codon is present in a reasonable (AGTAGGGATATGT)
consensus sequence for initiation (Kozak, 1989). The 495-bp
partial coding region encodes 165 amino acids that share 64,
55, and 56% identity with the corresponding regions of the a, b,
and g isoforms, respectively (Fig. 5 and Table I).
Tissue Distribution of the a, b, g, and d Isoform
mRNAs—Northern analysis performed with total RNA isolated
from several tissues and cell lines indicated a tissue-specific
distribution of the B9 subunit isoforms (Fig. 6). The transcripts
coding for B9a (;3.0 kb) and B9g (3.7 kb) are highly expressed in
brain (Fig. 6, A and C). A high level of expression of the B9g
mRNA was observed also in 3T3 D1, A432, bovine aorta smooth
muscle, and COS1 cell lines. There are three distinct transcripts
of ;1.7, 2.2, and 4.3 kb coding for B9b (Fig. 6B). The 4.3-kb
transcript is most abundant in testis, followed by brain, heart,
and skeletal muscle. The 1.7-kb transcript is more highly ex-
pressed in rabbit heart and spleen. The 2.2-kb transcript is de-
tectable in heart, testis, and brain. Three transcripts of 3.9, 3.1,
and 2.8 kb were detected for B9d (Fig. 6D). The 3.9-kb transcript
is most abundant in testis and brain followed by lung and L929
FIG. 2. Nucleotide and deduced amino acid sequences of the rabbit skeletal muscle B*a isoform of PP2A0. The sequence presented
is the combination of the overlapping B9a clones from Fig. 1: M 1-7B9a, M 5-4B9a, M 15-1B9a, M 9-1B9a, M 2-1B9a, M 5-1B9a, and M 1-8B9a. The
amino acid sequence is shown below the nucleotide sequence; both sequences are numbered on the right side. The dot represents the stop codon.
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cells. The 3.1-kb transcript seems to be present exclusively in rat
testis. The 2.8-kb message can be detected in several tissues but
is more abundant in rabbit testis. A higher molecular weight
transcript of 8.2-kb most prominent in brain was also observed.
Interaction of the Recombinant B9a with the AzC2 Form of
Protein Phosphatase 2A—Expression of B9a in E. coli produced
proteins of 53 or 55 kDa that were mostly insoluble. Growing
the cells at lower temperature did not improve the solubility of
FIG. 3. Nucleotide and deduced amino acid sequences of the rabbit skeletal muscle B*b isoforms of PP2A0. Combined sequences of
all the B9b cDNA clones in Fig. 1 are shown. Single underlines indicate the potential splice sites where the b1, 2, 3, and 4 isoforms diverge. The
double underline shows the polyadenylation signal, and the dots represent the stop codons.
Cloning of the Regulatory B9 Subunit of PP2A0 2583
 at UNIVERSITY OF DEBRECEN on June 24, 2013http://www.jbc.org/Downloaded from 
the protein. The difference in the size of the two polypeptides is
due to the presence of the His-tag (MGSSHHHHHHSS-
GLVPRGSHMLD) in the pET-15b plasmid, which adds 23
amino acids at the NH2 terminus of the protein. Antibodies to
the native B9 subunit recognize both polypeptide bands. Thus,
the apparent molecular weight of the B9a produced in E. coli is
very similar to the size of the B9 subunit (52.5 kDa) present in
the PP2A0 purified from rabbit skeletal muscle, even though
the deduced amino acid sequence predicted a protein of 57.6
kDa.
The NH2-terminal His-tag allowed a rapid purification of the
recombinant B9a by metal chelate affinity chromatography.
The insoluble B9a was solubilized in 6 M guanidine HCl and
renatured by 100-fold dilution, as described under “Experimen-
tal Procedures.” The solubilized B9a was then bound to Ni21-
NTA-agarose and eluted with 200 mM imidazole. SDS-PAGE
and Western analyses indicated that the purified protein was
nearly homogeneous (Fig. 7, A and B). Moreover, after purifi-
cation the protein was soluble. From 100 ml of E. coli culture,
3.8 mg of purified recombinant B9a was obtained.
We took advantage of the His-tag in a reconstitution exper-
iment to determine whether the recombinant protein could
associate with the AzC2 core of PP2A. Incubation of the purified
His-tagged B9a with dimeric PP2A (AzC2) and chromatography
of the mixture on Ni21-NTA-agarose generated a complex with
approximately equimolar amounts of the three subunits as
judged by SDS-PAGE and immunoblotting analyses utilizing
antibodies to the individual Aa, B9, and C2 subunits (Fig. 8, A,
upper and lower panels). The dimeric form of the phosphatase
did not bind to the column (Fig. 8, B, upper and lower panels).
These results strongly indicate that the B9 cDNAs encode reg-
ulatory subunits of PP2A that are able to interact with the
dimeric form to generate trimeric PP2A0 holoenzymes.
DISCUSSION
The PP2A has been isolated in a variety of trimeric forms
that differ in the associated B subunits. The 52-kDa and the
72–130-kDa constituents of the PP2A1 and the polycation-stim-
ulated protein phosphatase M holoenzymes, respectively, have
been previously cloned. In this paper we report the molecular
cloning of cDNAs encoding the B9 subunit of the previously
characterized PP2A0 (Zolnierowicz et al., 1994). Screening of
rabbit skeletal muscle and brain cDNA libraries has led to the
isolation of at least seven cDNA isotypes that fall into four
subgroups, termed a, b, g, and d. The b subgroup comprises
four isotypes that appear to be generated by alternative splic-
ing at the 39 end. Complete coding sequences have been ob-
tained for five isoforms, a, b2, b3, b4, and g (Fig. 5)
Eight of nine peptides isolated from the rabbit skeletal mus-
cle protein were found to be identical or to share high homology
with the predicted amino acid sequences of the B9 isoforms (Fig.
5). Three of the peptides have sequences identical to those in
the d isoform. It is possible that this was the predominant form
in our PP2A0 preparation and that sequences identical to those
of the other peptides would have been found if the complete
coding region had been isolated. The lack of complete identity
could also be explained either by errors in sequencing of the
peptides or by the presence of a mixture of different isoforms in
the purified phosphatase. Alternatively, not all the existing
isoforms have been isolated. Nevertheless, the reactivity of the
recombinant B9a with antibodies against the bovine heart B-
subunit, which we have shown to be of the B9 form (Zolnierow-
icz et al., 1994), and the ability of the recombinant protein to
associate with the AzC2 dimer, clearly indicate that the cloned
cDNAs encode B9 subunit isoforms.
The a encoding cDNAs predict a protein of 57.6 kDa. The
start codon is preceded 30 bp upstream by an in frame stop
codon. The presence of a deletion that eliminates the initiator
codon in one of the cDNAs suggests that alternative splice
variants of the a isoform may also exist. The b subgroup com-
prises four isotypes, b1, b2, b3, and b4, that most likely are
generated by alternative splicing at the 39 end. All four contain
an identical 442 amino acid region and diverge at their COOH
termini. The nucleotide sequence around the points of diver-
gence is in agreement with mammalian splice junction bound-
aries, AG/GT for b2 and b4, AG/GC for b3, and AG/CA for b1
(Senapathy et al., 1990). The detection of three B9b transcripts
by Northern analysis further supports the existence of multiple
forms. The nucleotide sequence surrounding the first ATG
(GGAGTCTAGATGT) is in moderate agreement with the con-
sensus sequence for initiation (Kozak, 1989). This putative
start codon is immediately preceded by a stop codon. The next
downstream potential initiation codon is at position 54. The
nucleotide sequence (GGCAGCAGGATGG) around this second
ATG complies better with the consensus sequence for transla-
tional initiation, but at this time it is not clear which one is
actually used.
Nucleotide and amino acid sequence analysis indicated that
all seven isoforms share a high degree of homology (Fig. 5, and
Table I). The a and b1, 2, 3, or 4 isoforms show ;58% nucleo-
tide and ;62% amino acid sequence identity. The g isoform
TABLE I
Nucleotide and deduced amino acid sequence comparison of B9 subunit isoforms of PP2A0
The upper left half shows the nucleotide sequence identity, and the lower right half shows the identities of the deduced amino acid sequences
among the rabbit B9 subunit isoforms and human brain (HuBr, T09026), human myeloid (HuMy, D26445), mouse (Mus, L26793), mouse testis
(MMT, X81059), RTS1 (U06630), and rice (RICC, D22057) present in GenBank. The letter followed by the numbers indicates the accession number
for each sequence. Numbers in parentheses show the homology based on the following grouping of conservative amino acids: Val, Ile, and Leu; Phe
and Tyr; Ala, Ser, and Thr; Asp and Glu; Asn and Gln; and Arg and Lys. The dash indicates that no overlapping region is present.
Identity
B9a B9b1 B9b2 B9b3 B9b4 B9g B9d HuBr HuMy Mus MMT RTS1 RICC
%
B9a 58 58 57 58 59 52 91 61 67 53 55 65
B9b1 62 (71) 98 98 94 68 53 68 85 87 57 61 62
B9b2 62 (71) 99 (99) 96 93 68 53 68 83 87 57 61 62
B9b3 62 (71) 97 (97) 99 (99) 92 69 53 68 91 87 60 56 62
B9b4 64 (74) 98 (98) 98 (98) 98 (98) 69 53 68 82 87 50 58 62
B9g 61 (71) 77 (83) 78 (83) 77 (83) 82 (87) 46 74 64 74 86 47 67
B9d 64 (76) 55 (63) 55 (63) 55 (63) 55 (63) 56 (63) 75 64 – – 48 –
HuBr 100 84 (88) 84 (88) 84 (88) 84 (88) 84 (90) 84 (88) 66 – – 46 66
HuMy 66 (74) 91 (91) 91 (91) 99 (99) 98 (98) 76 (80) 54 (63) 83 (84) 91 49 53 61
Mus 79 (89) 97 (97) 97 (97) 97 (97) 97 (97) 90 (96) – – 97 (97) – 62 58
MMT 28 (35) 48 (59) 50 (62) 46 (58) 58 (67) 90 (90) – – 66 (75) – 30 –
RTS1 53 (65) 56 (66) 56 (66) 56 (66) 56 (66) 50 (60) 36 (48) 67 (78) 56 (67) 69 (82) 15 (27) 59
RICC 64 (72) 64 (74) 64 (74) 64 (74) 64 (74) 65 (75) 66 (74) 64 (76) 50 (68) 63 (73)
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shares higher amino acid homology with the b isoforms (77–
82%) than with the a (61%). Conversely, the d is more similar
to the a (64%) than the g (56%) and the bs (55%). The homology
is higher in the central regions and diverges most at the NH2
and COOH termini (Fig. 3). Thus, one could speculate that the
homologous region may be involved in interaction with the A
and/or C2 subunits, whereas the termini could confer specific
properties to the holoenzyme. In support of this hypothesis, two
of the isoforms, g and b3, contain the bipartite nuclear local-
ization motif (K/R)(K/R)XXXXXXXXXXKXXKK (Dingwall and
Laskey, 1991; Robbins et al., 1991). This sequence may be
responsible for directing specific PP2A0 holoenzyme forms to
the nucleus. Indeed nuclear association of PP2A activity has
been described (Jakes et al., 1986; Turowski et al., 1995), al-
though the exact type of the enzyme is not known. The g
isoform also contains at the NH2 terminus an 8-fold glutamine-
proline (QP) repeat whose significance is not clear. Interest-
ingly the 74-kDa polypeptide present in the PP2A holoenzyme
isolated by Takeda and co-workers (Usui et al., 1988) is an
alternatively spliced variant of B9g.2 Thus, the enzyme of Usui
et al. (1988) belongs to the PP2A0 family.
2 M. Takeda, personal communication.
FIG. 4. Nucleotide and deduced amino acid sequences of the rabbit skeletal muscle and brain B*g isoforms of PP2A0. A combined
sequence of the muscle and brain cDNA clones in Fig. 1 is shown. The dot indicates the stop codon.
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FIG. 5. Alignment of amino acid sequences of different B* subunit isoforms. Deduced amino acid sequences of the rabbit skeletal muscle
(RSM) and brain (RB) B9 subunit isoforms, human myeloid cell cDNA (HUMORFY)), and S. cerevisiae rox3 suppressor gene product, Rts1p, were
aligned with the sequence of the B9a isoform. Identical amino acids are designated by small dots; dashed lines indicate gaps, and solid diamonds
designate stop codons. The numbers in the Rts1p sequence indicate residues that were not included in the alignment. The peptide sequences
obtained from the purified rabbit skeletal muscle (RSM B9 Peptide) B9 subunit are also shown. The underlined sequences indicate the putative
nuclear localization signals.
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The tissue-specific expression of the B9 isoforms is also in
keeping with the idea that different isoforms of the B9 subunit
may direct the enzymes to different cellular functions. The a
and g mRNAs are more abundant in brain. The 4.3-kb tran-
script of b is highly expressed in testis, whereas the 1.7-kb
message is more abundant in heart and spleen. Testis, lung
and brain express the highest level of d mRNA.
Data base searches revealed no homology between the B9
subunit isoforms and the other known B-subunits of PP2A,
including the small and middle SV40 and polyoma virus tumor
antigens. However, matches with several other nucleotide se-
quences present in GenBank were found. The protein sequence
deduced from a 382-bp cDNA, T09026 (Adams et al., 1993), is
identical to a region of B9a if the T and the G at positions 339
and 373 of the EST clone are deleted. A human open reading
frame, HUMORFY (D26445, 3702 bp), shares more than 90%
identity with the B9b group at the level of amino acids (Table I).
Comparison of the amino acid sequence of HUMORFY with the
B9b3 revealed that the human clone contains a deletion corre-
sponding to amino acids 442–480 of the B9b3, but the down-
stream sequences are almost identitical. Interestingly, the
B9b4 clone starts to diverge from the other three b isotypes at
the position where the deletion in the HUMORFY starts, and
b1, b2, and b3 diverge from each other at the point where the
deletion ends (Fig. 5). These positions correspond to potential
splice junctions. Therefore, it is possible that a fifth alternative
spliced form of B9b exists.
Two mouse clones in the data base also share high homology
with the B9 isoforms. The 332-bp sequence of MUSF354A
(L26793) codes for a protein that is 97, 79, and 90% identical
with B9b, B9a, and B9g, respectively, if minor changes are
introduced. The other mouse clone, MMTEG271G (X81059) is
86 and 90% identical to the B9g at the level of nucleotides and
amino acids, respectively. These clones appear to represent the
mouse b and g isotype of B9. In addition a rice 419-bp cDNA
clone, RICC102651 (D22057), was found to have 64–65%
amino acid identity with the rabbit B9 isoforms.
An especially interesting match was found with a S. cerevi-
siae gene (U06630), isolated as a high copy suppressor of rox3
FIG. 6.Northern analysis of the B*a,
b, g, and d mRNA. Total RNA (20 mg/
lane) from different rabbit and rat tissues
and cell lines was electrophoresed
through an agarose gel under denaturing
conditions and transferred to a nitrocellu-
lose membrane. The bound RNA was hy-
bridized with: 32P-labeled B9a (1338 bp, M
2-1B9a cDNA) (A), 32P-labeled B9b (1157
bp, M 6-2B9b, cDNA) (B), 32P-labeled B9g
(641 bp, M PCR cDNA) (C), and 32P-la-
beled B9d (594 bp, 39 end SmaI–EcoRI
fragment of BR 6-1B9d cDNA) (D). The
ribosomal RNA stained with ethidium
bromide is shown below the autoradio-
grams. The numbers on the right sides
indicate the sizes of the molecular mark-
ers in kilobases. The numbers and arrows
on the left sides designate the sizes of the
B9 subunit transcripts. The migration of
the 28 S and 18 S ribosomal RNAs is
indicated in B. Sk. Muscle, skeletal mus-
cle; Bovine Ao.Sm.M.C., bovine aorta
smooth muscle cells.
FIG. 7. Purification of His-tagged B*a expressed in E. coli. The
B9a polypeptide expressed from the pET-15b vector was solubilized,
renatured, and purified on a Ni21-NTA-agarose resin as described un-
der “Experimental Procedures.” A, Coomassie Blue staining of samples
separated on 9% SDS-PAGE. B, Western blot using antibody raised
against B9 subunit of bovine heart PP2A0. Fl.t., flow through fraction;
Wash 1, fractions eluted with 5 mM imidazole in 25 mM Tris-HCl (pH
7.5) and 0.8 M NaCl; Wash 2, fractions eluted with 20 mM imidazole in
25 mM Tris-HCl (pH 7.5) and 0.8 M NaCl; lanes 1–7, fractions eluted
with 200 mM imidazole in 25 mM Tris-HCl (pH 7.5) and 0.8 M NaCl.
Samples of 15 ml from each fraction were loaded onto the gel. The
numbers at the sides of the panels indicate molecular mass markers: 94
kDa, phosphorylase b; 67 kDa, bovine serum albumin; 53 kDa, glutamic
dehydrogenase; 43 kDa, ovalbumin; and 30 kDa, carbonic anhydrase.
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mutants, RTS1.3 Rts1p showed high homology (53–56% iden-
tity at the protein level) with the B9 isoforms. The same gene
has also been isolated as a high copy suppressor, SCS1, of a
yeast hsp60 mutant strain (Shu and Hallberg, 1995). Deletion
of the suppressor gene results in temperature-sensitive strains.
Overexpression of the mammalian cDNAs in yeast disrupted
strains rescues the temperature sensitivity.4 In addition, PP2A
activity co-immunoprecipitates with Rts1 protein. These re-
sults indicate that Rts1p and the B9 subunit are functional
homologs and support the notion that the various B-subunits of
PP2A confer specificity to the enzyme. Defects in Cdc55p, the S.
cerevisiae homolog of the B subunit, result in multiple elon-
gated buds and defective cytokinesis (Healy et al., 1991). This
phenotype is different from that elicited by disruption of RTS1,
which encodes the yeast B9 homolog. Furthermore, overexpres-
sion of Rts1p does not rescue the defect in cdc55 cells. Thus, the
B and B9 subunits appear to target the phosphatase to distinct
subsets of substrates and consequently direct the enzyme to
control different cellular functions.
Although there are only two C2 catalytic subunit isoforms of
PP2A, the number of the potential combinatorial associations
of the different A and B/B9/B0 regulatory subunit forms is very
large. Counting two A, two C2, three B, two B0, and possibly as
many as ten B9 subunit isoforms a total of some sixty different
trimeric PP2A holoenzymes could be generated that may be
able to cope with the large number of cellular functions in
which this form of phosphatase has been implicated.
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FIG. 8. Reconstitution of the AzB*azC2 trimeric holoenzyme
form of protein phosphatase 2A0. AzC2 dimeric PP2A was incubated
with (A) and without (B) recombinant B9a as described under “Experi-
mental Procedures.” The mixture was then subjected to chromatogra-
phy on Ni21-NTA resin. The upper panels show Coomassie Blue-stained
samples separated by SDS-PAGE, and the lower panels show Western
blotting of the same samples. The Western blot was carried out with
antibodies against human Aa, bovine heart B9, and C2. Panel A, B9a,
0.4 mg of purified recombinant B9a; PP2A2, 1.6 mg of purified rabbit
skeletal muscle AzC2 dimer; lane 1, flow through fraction; lanes 2–5,
fractions eluted with 20 mM imidazole in 25 mM Tris-HCl (pH 7.5) and
0.2 M NaCl; lanes 6–9, fractions eluted with 200 mM imidazole in 25 mM
Tris-HCl (pH 7.5) and 0.2 M NaCl. Panel B, lane 1, flow through
fraction; lanes 2–4, fractions eluted with 20 mM imidazole in 25 mM
Tris-HCl (pH 7.5) and 0.2 M NaCl; lanes 5–7, fractions eluted with 200
mM imidazole in 25 mM Tris-HCl (pH 7.5) and 0.2 M NaCl. Samples of 10
ml from each fraction were loaded onto the gel. The numbers at the left
sides of the panels indicate molecular mass markers. A, B9, and C
designate the position of the subunits.
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